A recent study reports that using reduced amounts of approved immunotherapy for malignant melanoma may lead to better control of tumors while also limiting side effects. The findings come from researchers at Karolinska Institutet and were…
A recent study reports that using reduced amounts of approved immunotherapy for malignant melanoma may lead to better control of tumors while also limiting side effects. The findings come from researchers at Karolinska Institutet and were…